Onconetix (ONCO) Interest Coverage Ratio (2021 - 2026)
Onconetix (ONCO) posted quarterly Interest Coverage Ratio of 4556.95 for Q1 2026, down 8005.26% year-over-year from 57.64 in Q1 2025, and down 65982.18% quarter-over-quarter from 6.9 in Q3 2025.
Onconetix (ONCO) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Onconetix (ONCO) has reported Interest Coverage Ratio for 6 consecutive years, with 4556.95 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio fell 8005.26% year-over-year to 4556.95; the TTM figure through Mar 2026 stood at 29.52 (up 47.36% YoY), while the FY2025 annual figure was 0.89, up 67.87% from the prior year.
- Interest Coverage Ratio eased to 4556.95 in Q1 2026 per ONCO's latest filing, from 6.9 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.0 in Q2 2022 and bottomed at 4556.95 in Q1 2026.
- Historically, Interest Coverage Ratio has averaged 331.29 across 5 years, with a median of 11.42 in 2024.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio plunged 410773211.64% — and 2025, when it surged 86.93%.
- Onconetix's Interest Coverage Ratio stood at 4.84 in 2022, then tumbled by 2314.53% to 116.95 in 2023, then surged by 33.26% to 78.05 in 2024, then jumped by 91.16% to 6.9 in 2025, then sank by 65982.18% to 4556.95 in 2026.
- Business Quant data shows ONCO's Interest Coverage Ratio at 4556.95 in Q1 2026, 6.9 in Q3 2025, and 8.68 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Onconetix | 1.44 Mn | -4.50 Mn | 4,303.00 | -622.19 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -622.19 |
| Mar 31, 2026 | -4,556.95 |
| Sep 30, 2025 | -6.90 |
| Jun 30, 2025 | -8.68 |
| Mar 31, 2025 | -56.22 |
| Dec 31, 2024 | -78.05 |
| Sep 30, 2024 | -11.42 |
| Jun 30, 2024 | -66.37 |
| Mar 31, 2024 | -27.70 |
| Dec 31, 2023 | -116.95 |
| Sep 30, 2023 | -16.36 |
| Jun 30, 2023 | -10.67 |
| Mar 31, 2023 | -4.48 |
| Dec 31, 2022 | -4.84 |
| Sep 30, 2022 | -3.71 |
| Jun 30, 2022 | 0.00 |
| Dec 31, 2021 | -2.26 |